Northwest Biotherapeutics Stock Analysis
| NWBO Stock | USD 0.51 0.01 2.00% |
Northwest Biotherapeutics is overvalued with Real Value of 0.44 and Hype Value of 0.51. The main objective of Northwest Biotherapeutics otc analysis is to determine its intrinsic value, which is an estimate of what Northwest Biotherapeutics is worth, separate from its market price. There are two main types of Northwest Biotherapeutics' stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Northwest Biotherapeutics' performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Northwest Biotherapeutics' stock to identify patterns and trends that may indicate its future price movements.
The Northwest Biotherapeutics otc stock is traded in the USA on OTCQB Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Northwest Biotherapeutics is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. Northwest OTC Stock trading window is adjusted to America/New York timezone. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Northwest Biotherapeutics' ongoing operational relationships across important fundamental and technical indicators.
Northwest |
Northwest OTC Stock Analysis Notes
The company recorded a loss per share of 0.06. Northwest Biotherapeutics had not issued any dividends in recent years. The entity had 1:16 split on the 26th of September 2012. Northwest Biotherapeutics, Inc., a biotechnology company, develops personalized immune therapies for cancer in the United States and internationally. The company was founded in 1996 and is headquartered in Bethesda, Maryland. Northwest Bioth operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 19 people.The quote for Northwest Biotherapeutics is listed on Over The Counter exchange (i.e., OTC), and the entity is not required to meet listing requirements such as those found on the Nasdaq, NYSE, or AMEX exchanges. To find out more about Northwest Biotherapeutics contact Linda Powers at 240 497-9024 or learn more at www.nwbio.com.Northwest Biotherapeutics Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more otcs at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Northwest Biotherapeutics' investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Northwest Biotherapeutics or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
| Northwest Biotherapeutics generated a negative expected return over the last 90 days | |
| Northwest Biotherapeutics has some characteristics of a very speculative penny stock | |
| Northwest Biotherapeutics has high historical volatility and very poor performance | |
| Northwest Biotherapeutics has high likelihood to experience some financial distress in the next 2 years | |
| The company currently holds 25.16 M in liabilities. Northwest Biotherapeutics has a current ratio of 0.1, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Northwest Biotherapeutics until it has trouble settling it off, either with new capital or with free cash flow. So, Northwest Biotherapeutics' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Northwest Biotherapeutics sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Northwest to invest in growth at high rates of return. When we think about Northwest Biotherapeutics' use of debt, we should always consider it together with cash and equity. | |
| Northwest Biotherapeutics currently holds about 9.43 M in cash with (38.3 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01. |
Northwest Biotherapeutics Upcoming and Recent Events
Earnings reports are used by Northwest Biotherapeutics to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Northwest Biotherapeutics previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 27th of February 2024 Upcoming Quarterly Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View |
Northwest Market Capitalization
The company currently falls under 'Small-Cap' category with a current market capitalization of 705.3 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Northwest Biotherapeutics's market, we take the total number of its shares issued and multiply it by Northwest Biotherapeutics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Northwest Profitablity
Northwest Biotherapeutics' profitability indicators refer to fundamental financial ratios that showcase Northwest Biotherapeutics' ability to generate income relative to its revenue or operating costs. If, let's say, Northwest Biotherapeutics is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Northwest Biotherapeutics' executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Northwest Biotherapeutics' profitability requires more research than a typical breakdown of Northwest Biotherapeutics' financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of 52.11 %, which can signify that it executes well on its competitive strategies and has good control over its expenditures. This is very large. Similarly, it shows Operating Margin (OM) of (54.95) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $54.95. Technical Drivers
As of the 19th of April, Northwest Biotherapeutics secures the Standard Deviation of 3.87, mean deviation of 2.69, and Risk Adjusted Performance of (0.02). In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Northwest Biotherapeutics, as well as the relationship between them. Strictly speaking, you can use this information to find out if the firm will indeed mirror its model of past prices, or the prices will eventually revert. We have analyzed thirteen technical drivers for Northwest Biotherapeutics, which can be compared to its peers in the industry. Please verify Northwest Biotherapeutics risk adjusted performance, variance, as well as the relationship between the Variance and potential upside to decide if Northwest Biotherapeutics is priced some-what accurately, providing market reflects its recent price of 0.51 per share. As Northwest Biotherapeutics is a penny stock we also strongly advise to check its jensen alpha numbers.Northwest Biotherapeutics Price Movement Analysis
The output start index for this execution was two with a total number of output elements of fifty-nine. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Northwest Biotherapeutics middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Northwest Biotherapeutics. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Northwest Biotherapeutics Predictive Daily Indicators
Northwest Biotherapeutics intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Northwest Biotherapeutics otc stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Northwest Biotherapeutics Forecast Models
Northwest Biotherapeutics' time-series forecasting models are one of many Northwest Biotherapeutics' otc stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Northwest Biotherapeutics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Northwest OTC Stock Analysis
OTC Stock analysis is the technique used by a trader or investor to examine and evaluate how Northwest Biotherapeutics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Northwest shares will generate the highest return on investment. We also built our otc analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual OTC such as Northwest Biotherapeutics. By using and applying Northwest OTC Stock analysis, traders can create a robust methodology for identifying Northwest entry and exit points for their positions.
Northwest Biotherapeutics, Inc., a biotechnology company, develops personalized immune therapies for cancer in the United States and internationally. The company was founded in 1996 and is headquartered in Bethesda, Maryland. Northwest Bioth operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 19 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our otc stock analysis tools, you can find out how much better you can do when adding Northwest Biotherapeutics to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Instant Ratings Now
Instant RatingsDetermine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |
| All Next | Launch Module |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Northwest Biotherapeutics. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics. Note that the Northwest Biotherapeutics information on this page should be used as a complementary analysis to other Northwest Biotherapeutics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Complementary Tools for Northwest OTC Stock analysis
When running Northwest Biotherapeutics' price analysis, check to measure Northwest Biotherapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Northwest Biotherapeutics is operating at the current time. Most of Northwest Biotherapeutics' value examination focuses on studying past and present price action to predict the probability of Northwest Biotherapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Northwest Biotherapeutics' price. Additionally, you may evaluate how the addition of Northwest Biotherapeutics to your portfolios can decrease your overall portfolio volatility.
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |